Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccines in participants >/=3 years of age: a double-blind, randomized, parallel-controlled phase III clinical trial in China

• Main Authors: Shi-Yuan Wang (Author), Shu-Zhen Liu (Author), Kai Chu (Author), Yue Zhao (Author), Feng-Cai Zhu (Author), Yue-Mei Hu (Author), Fan-Yue Meng (Author), Jing-Xin Li (Author), Li Luo (Author), Jia-Ying Yang (Author), Pei Liu (Author), Jun Yu (Author)
• Format: Book
• Published: Taylor & Francis Group, 2017-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Viruses from two antigenically distinct influenza B strains have co-circulated since the mid-1980s, yet inactivated trivalent influenza vaccines (TIVs) with either the Victoria or Yamagata lineage could only provide limited protection from influenza B strain. Quadrivalent influenza vacci...